TABLE 2.
Treatment characteristics of study cohort from “EnPHC-Eva: Facility” Malaysia, 2018-2019 (N = 2,696).
Variable | n (%) |
---|---|
Medication burden | |
Total number of medications per day, mean (SD) | 4.8 (1.7) |
Categories, by quantity | |
1–2 | 221 (8.2) |
3–4 | 942 (34.9) |
5–6 | 1,081 (40.1) |
≥7 | 452 (16.8) |
Number of antidiabetic medications per day, mean (SD) | 1.3 (0.7) |
Percentage of total medication count, % | 27.1 |
Categories, by quantity | |
1 | 1,608 (59.6) |
2 | 935 (34.7) |
3–4 | 153 (5.7) |
Medication regimen complexity | |
Total patient-level MRCI score, mean (SD) | 15.1 (4.9) |
(i) Dosage form score, mean (SD) | 2.0 (1.5) |
Percentage of total pMRCI score, % | 13.2 |
(ii) Dosing frequency score, mean (SD) | 6.7 (2.4) |
Percentage of total pMRCI score, % | 44.4 |
(iii) Additional directions score, mean (SD) | 6.4 (2.4) |
Percentage of total pMRCI score, % | 42.4 |
Diabetes-specific MRCI, mean (SD) | 7.9 (3.0) |
Percentage of total pMRCI score, (%) | 52.9 |
(i) Dosage form score, mean (SD) | 1.8 (1.2) |
Percentage of total dMRCI score, % | 22.8 |
(ii) Dosing frequency score, mean (SD) | 3.2 (1.2) |
Percentage of total dMRCI score, % | 40.5 |
(iii) Additional directions score, mean (SD) | 2.9 (1.3) |
Percentage of total dMRCI score, % | 36.7 |
Medication adherence | |
Patient-level PDC, mean (SD) | 0.90 (0.15) |
Categories, by PDC level | |
<80% | 512 (19.0) |
80–89% | 403 (14.9) |
≥90% | 1,781 (66.1) |
Diabetes-specific PDC, mean (SD) | 0.91 (0.15) |
Categories, by PDC level | |
<80% | 471 (17.5) |
80–89% | 311 (11.5) |
≥90% | 1,914 (71.0) |
Abbreviations: dMRCI, diabetes-specific medication regimen complexity index; PDC, proportion days covered; pMRCI, patient-level medication regimen complexity index; SD, standard deviation.